Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $40,750 | 8 | 99.7% |
| Food and Beverage | $124.45 | 8 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Applied Therapeutics, inc. | $40,750 | 8 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $37.10 | 3 | $0 (2019) |
| SK Life Science, Inc. | $31.46 | 2 | $0 (2024) |
| Vertical Pharmaceuticals, LLC | $26.22 | 1 | $0 (2024) |
| UCB, Inc. | $14.96 | 1 | $0 (2020) |
| Lundbeck LLC | $14.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.10 | 2 | Vertical Pharmaceuticals, LLC ($26.22) |
| 2023 | $18,250 | 5 | Applied Therapeutics, inc. ($18,250) |
| 2022 | $22,500 | 3 | Applied Therapeutics, inc. ($22,500) |
| 2021 | $16.58 | 1 | SK Life Science, Inc. ($16.58) |
| 2020 | $14.96 | 1 | UCB, Inc. ($14.96) |
| 2019 | $37.10 | 3 | Sunovion Pharmaceuticals Inc. ($37.10) |
| 2017 | $14.71 | 1 | Lundbeck LLC ($14.71) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.88 | General |
| 06/27/2024 | Vertical Pharmaceuticals, LLC | Relexxii (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Neurology - ADHD medication | ||||||
| 10/17/2023 | Applied Therapeutics, inc. | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 06/27/2023 | Applied Therapeutics, inc. | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 03/14/2023 | Applied Therapeutics, inc. | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 03/14/2023 | Applied Therapeutics, inc. | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 03/14/2023 | Applied Therapeutics, inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 09/14/2022 | Applied Therapeutics, inc. | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 08/02/2022 | Applied Therapeutics, inc. | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 06/17/2022 | Applied Therapeutics, inc. | — | Consulting Fee | Cash or cash equivalent | $13,000.00 | General |
| 12/06/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.58 | General |
| 02/03/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Neurology | ||||||
| 07/22/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: CNS | ||||||
| 02/26/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: CNS | ||||||
| 01/29/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: CNS | ||||||
| 10/11/2017 | Lundbeck LLC | ONFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 444 | 626 | $210,842 | $69,139 |
| 2022 | 7 | 259 | 378 | $55,741 | $37,904 |
| 2021 | 6 | 344 | 532 | $94,796 | $52,825 |
| 2020 | 7 | 363 | 611 | $112,150 | $59,717 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 121 | 212 | $41,048 | $14,252 | 34.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 78 | $81,312 | $14,041 | 17.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 94 | $27,572 | $9,499 | 34.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 75 | 75 | $13,185 | $8,374 | 63.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 46 | $20,738 | $6,765 | 32.6% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 18 | 18 | $7,030 | $4,560 | 64.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 48 | 50 | $6,520 | $4,337 | 66.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 18 | 19 | $5,236 | $3,574 | 68.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 13 | 13 | $4,693 | $2,853 | 60.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 21 | $3,508 | $885.44 | 25.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 56 | 104 | $14,261 | $9,212 | 64.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 26 | 48 | $11,323 | $8,986 | 79.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 77 | 125 | $11,551 | $7,729 | 66.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $6,675 | $5,349 | 80.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 36 | $8,890 | $4,222 | 47.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 21 | 21 | $2,496 | $1,957 | 78.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 13 | $545.35 | $447.84 | 82.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 110 | 227 | $21,475 | $14,225 | 66.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 70 | 72 | $26,290 | $12,557 | 47.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 25 | 45 | $13,233 | $8,562 | 64.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 69 | 72 | $21,452 | $8,370 | 39.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 49 | 92 | $10,322 | $8,303 | 80.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 24 | $2,024 | $807.52 | 39.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 113 | 263 | $30,274 | $16,677 | 55.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 67 | 68 | $25,744 | $12,100 | 47.0% |
About Dr. Eric Mittelmann, MD
Dr. Eric Mittelmann, MD is a Neurology healthcare provider based in Paramus, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2012. The National Provider Identifier (NPI) number assigned to this provider is 1215291240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Mittelmann, MD has received a total of $40,874 in payments from pharmaceutical and medical device companies, with $41.10 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($40,750).
As a Medicare-enrolled provider, Mittelmann has provided services to 1,410 Medicare beneficiaries, totaling 2,147 services with total Medicare billing of $219,585. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Paramus, NJ
- Active Since 06/25/2012
- Last Updated 04/17/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1215291240
Products in Payments
- APTIOM (Drug) $37.10
- Relexxii (Drug) $26.22
- Briviact (Drug) $14.96
- ONFI (Drug) $14.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Paramus
Dr. Yeva Fernandez, M.d, M.D
Neurology — Payments: $27,894
Elana Clar, M.d, M.D
Neurology — Payments: $10,485
Theodore Conte, Md,, MD,
Neurology — Payments: $5,544
Osama Abu-Hadid, M.d, M.D
Neurology — Payments: $2,517
Dr. Umer Akbar, Md, MD
Neurology — Payments: $761.86
Dr. Barbara Gordon-Kundu, Md, MD
Neurology — Payments: $35.88